JP2024541334A5 - - Google Patents
Info
- Publication number
- JP2024541334A5 JP2024541334A5 JP2024527498A JP2024527498A JP2024541334A5 JP 2024541334 A5 JP2024541334 A5 JP 2024541334A5 JP 2024527498 A JP2024527498 A JP 2024527498A JP 2024527498 A JP2024527498 A JP 2024527498A JP 2024541334 A5 JP2024541334 A5 JP 2024541334A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- amino acid
- tmmp
- acid sequence
- terminus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163283028P | 2021-11-24 | 2021-11-24 | |
| US63/283,028 | 2021-11-24 | ||
| US202263309288P | 2022-02-11 | 2022-02-11 | |
| US63/309,288 | 2022-02-11 | ||
| US202263338131P | 2022-05-04 | 2022-05-04 | |
| US63/338,131 | 2022-05-04 | ||
| PCT/US2022/080263 WO2023097188A1 (en) | 2021-11-24 | 2022-11-21 | T-cell modulatory multimeric polypeptides and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541334A JP2024541334A (ja) | 2024-11-08 |
| JP2024541334A5 true JP2024541334A5 (https=) | 2025-10-31 |
Family
ID=86540434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527498A Pending JP2024541334A (ja) | 2021-11-24 | 2022-11-21 | Ｔ細胞調節多量体ポリペプチドおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240317815A1 (https=) |
| EP (1) | EP4436600A4 (https=) |
| JP (1) | JP2024541334A (https=) |
| KR (1) | KR20240114745A (https=) |
| AU (1) | AU2022398342A1 (https=) |
| CA (1) | CA3236566A1 (https=) |
| IL (1) | IL312485A (https=) |
| WO (1) | WO2023097188A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2973548T3 (es) | 2016-12-22 | 2024-06-20 | Cue Biopharma Inc | Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| WO2025207816A1 (en) * | 2024-03-27 | 2025-10-02 | Cue Biopharma, Inc. | Treatment of b-cell mediated immune disorders by t-cell mediated depletion of b cells, plasmablasts and plasma cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103649125A (zh) * | 2011-06-22 | 2014-03-19 | 霍夫曼-拉罗奇有限公司 | 利用包含mhc i类的复合物通过循环中的病毒特异性细胞毒性t细胞清除靶细胞 |
| WO2019051126A1 (en) * | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | ANTIGEN PRESENTING POLYPEPTIDES COMPRISING CHEMICAL CONJUGATION SITES AND METHODS OF USE THEREOF |
| WO2020181273A1 (en) * | 2019-03-06 | 2020-09-10 | Cue Biopharma, Inc. | Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof |
| WO2020181272A1 (en) * | 2019-03-06 | 2020-09-10 | Cue Biopharma, Inc. | Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof |
| KR20220015382A (ko) * | 2019-05-29 | 2022-02-08 | 큐 바이오파마, 인크. | 다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법 |
| WO2021195108A1 (en) * | 2020-03-24 | 2021-09-30 | Cue Biopharma, Inc. | T cell modulatory polypeptides and methods of use thereof |
-
2022
- 2022-11-21 WO PCT/US2022/080263 patent/WO2023097188A1/en not_active Ceased
- 2022-11-21 IL IL312485A patent/IL312485A/en unknown
- 2022-11-21 KR KR1020247019611A patent/KR20240114745A/ko active Pending
- 2022-11-21 AU AU2022398342A patent/AU2022398342A1/en active Pending
- 2022-11-21 CA CA3236566A patent/CA3236566A1/en active Pending
- 2022-11-21 EP EP22899490.1A patent/EP4436600A4/en active Pending
- 2022-11-21 JP JP2024527498A patent/JP2024541334A/ja active Pending
-
2024
- 2024-06-06 US US18/736,261 patent/US20240317815A1/en not_active Abandoned
-
2025
- 2025-05-14 US US19/208,098 patent/US20250376491A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024541334A5 (https=) | ||
| JP2022534846A5 (https=) | ||
| AU2016336866B2 (en) | Multivalent Fv antibodies | |
| US12509495B2 (en) | LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and LAG-3 antigen binding domains | |
| EP2794658B1 (en) | Bispecific antibody molecule | |
| EP3472205B1 (en) | Chimeric antigen receptor | |
| JP2022535130A5 (https=) | ||
| JP2023527049A5 (https=) | ||
| JP2020511949A5 (https=) | ||
| JP2018525006A5 (https=) | ||
| CA3199447A1 (en) | Fusions with cd8 antigen binding molecules for modulating immune cell function | |
| US20230028399A1 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| JP2022536581A5 (https=) | ||
| JP2024512470A5 (https=) | ||
| KR20240032732A (ko) | 암 면역요법을 위한 투약 요법 | |
| JP2022545815A5 (https=) | ||
| JP2023500573A5 (https=) | ||
| CA3146903A1 (en) | Modified cytotoxic t cells and methods of use thereof | |
| JP2023532278A5 (https=) | ||
| JP2024504162A5 (https=) | ||
| JP2024507693A5 (https=) | ||
| JP2022548112A5 (https=) | ||
| JP2025508958A (ja) | 抗癌剤としての免疫細胞機能のａｔｐ依存性アゴニスト | |
| JP2024502094A5 (https=) | ||
| CN120826234A (zh) | 抗EGFRvIII/抗CD3抗体与肿瘤靶向性4-1BB激动剂的组合疗法 |